BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 19319842)

  • 1. Nitric oxide and vascular insulin resistance.
    Wu G; Meininger CJ
    Biofactors; 2009; 35(1):21-7. PubMed ID: 19319842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells.
    Shi W; Meininger CJ; Haynes TE; Hatakeyama K; Wu G
    Cell Biochem Biophys; 2004; 41(3):415-34. PubMed ID: 15509890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells.
    Cai S; Khoo J; Channon KM
    Cardiovasc Res; 2005 Mar; 65(4):823-31. PubMed ID: 15721862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
    Channon KM
    Trends Cardiovasc Med; 2004 Nov; 14(8):323-7. PubMed ID: 15596110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and endothelial cell dysfunction: studies in mammalian models.
    Kearney MT; Duncan ER; Kahn M; Wheatcroft SB
    Exp Physiol; 2008 Jan; 93(1):158-63. PubMed ID: 17933859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahydrobiopterin increases insulin sensitivity in patients with type 2 diabetes and coronary heart disease.
    Nyström T; Nygren A; Sjöholm A
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E919-25. PubMed ID: 15265759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease.
    Schmidt TS; Alp NJ
    Clin Sci (Lond); 2007 Jul; 113(2):47-63. PubMed ID: 17555404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (6R)-5,6,7,8-tetrahydro-L-biopterin and its stereoisomer prevent ischemia reperfusion injury in human forearm.
    Mayahi L; Heales S; Owen D; Casas JP; Harris J; MacAllister RJ; Hingorani AD
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1334-9. PubMed ID: 17413035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahydrobiopterin: biochemistry and pathophysiology.
    Werner ER; Blau N; Thöny B
    Biochem J; 2011 Sep; 438(3):397-414. PubMed ID: 21867484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis.
    Matei V; Rodríguez-Vilarrupla A; Deulofeu R; Colomer D; Fernández M; Bosch J; Garcia-Pagán JC
    Hepatology; 2006 Jul; 44(1):44-52. PubMed ID: 16799985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen peroxide stimulates tetrahydrobiopterin synthesis through the induction of GTP-cyclohydrolase I and increases nitric oxide synthase activity in vascular endothelial cells.
    Shimizu S; Shiota K; Yamamoto S; Miyasaka Y; Ishii M; Watabe T; Nishida M; Mori Y; Yamamoto T; Kiuchi Y
    Free Radic Biol Med; 2003 May; 34(10):1343-52. PubMed ID: 12726922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GTP cyclohydrolase I gene transfer reverses tetrahydrobiopterin deficiency and increases nitric oxide synthesis in endothelial cells and isolated vessels from diabetic rats.
    Meininger CJ; Cai S; Parker JL; Channon KM; Kelly KA; Becker EJ; Wood MK; Wade LA; Wu G
    FASEB J; 2004 Dec; 18(15):1900-2. PubMed ID: 15467010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial nitric oxide synthase in vascular disease: from marvel to menace.
    Förstermann U; Münzel T
    Circulation; 2006 Apr; 113(13):1708-14. PubMed ID: 16585403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of tetrahydrobiopterin attenuates testicular damage by reducing nitric oxide synthase activity in a cryptorchid mouse model.
    Kondo Y; Ishikawa T; Yamaguchi K; Yada T; Fujisawa M
    J Androl; 2008; 29(2):153-63. PubMed ID: 17978343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide and the endothelium: history and impact on cardiovascular disease.
    Yetik-Anacak G; Catravas JD
    Vascul Pharmacol; 2006 Nov; 45(5):268-76. PubMed ID: 17052961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen-induced radical intermediates in the nNOS oxygenase domain regulated by L-arginine, tetrahydrobiopterin, and thiol.
    Berka V; Wang LH; Tsai AL
    Biochemistry; 2008 Jan; 47(1):405-20. PubMed ID: 18052254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydrobiopterin and nitric oxide synthase dimer levels are not changed following hypoxia-ischemia in the newborn rat.
    Wainwright MS; Arteaga E; Fink R; Ravi K; Chace DH; Black SM
    Brain Res Dev Brain Res; 2005 May; 156(2):183-92. PubMed ID: 16099305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental changes in nitric oxide synthesis in the ovine placenta.
    Kwon H; Wu G; Meininger CJ; Bazer FW; Spencer TE
    Biol Reprod; 2004 Mar; 70(3):679-86. PubMed ID: 14613894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of a novel silicate inositol complex of the nitric oxide precursor arginine in the obese insulin-resistant JCR:LA-cp rat.
    Proctor SD; Kelly SE; Vine DF; Russell JC
    Metabolism; 2007 Oct; 56(10):1318-25. PubMed ID: 17884439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.